Overview

A Window of Opportunity Study to Assess the Modulation of Biomarkers in Head and Neck Squamous Cell Cancer (HNSCC) By Preoperative Treatment With BYL719

Status:
Unknown status
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
Single centre, single arm, preoperative window of opportunity study with a biomarker endpoint (expression profiling by RNA sequencing). Patients with resectable, histologically confirmed head and neck squamous cell carcinoma (HNSCC) for whom surgical treatment is planned as definitive management will be eligible.
Phase:
N/A
Details
Lead Sponsor:
Lawson Health Research Institute